mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.2 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
0.23 |
0.2 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.2 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.2 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.2 |
mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.2 |